Fused Heterocyclic Steroids: A Systematic Synthetic Programme, 1950–1951
Fusing heterocyclic rings to the steroid nucleus later became an important strategy in medicinal chemistry. Pyrrolo-, indolo-, thiazolo-, pyrazolo-, pyrimidino- and other heterocyclic steroids were subsequently investigated for anabolic, anti-inflammatory, cardiovascular, antimicrobial, antitumour and other biological properties.
A systematic programme of this kind is documented in the 1950 doctoral thesis of Hekmat Bechir Fathallah Antaki, Contributions to the Chemistry of Heterocyclic Compounds, submitted at Queen Mary College, University of London (DOI: 10.17636/101132126).
The Field Before 1950, and What the Programme Added
As surveyed by Antaki in Part II of his 1950 doctoral thesis (pp. 83–94), two strands of steroid chemistry existed side by side. Basic steroid derivatives (including amino and guanido compounds) had been prepared for biological investigation, and nitrogen-containing heterocycles were known among naturally occurring steroidal alkaloids such as solanidine, jervine and conessine. Fused heterocyclic steroids, however, were represented by scattered examples: Dorée's indolo-coprostane (1909), Borsche and Frank's quinolino derivatives of keto-cholanic acids (1924), and Dorée and Petrow's indolo-cholestane (1935).
Antaki saw an opportunity to investigate these reactions systematically. Rather than claim a new class of compounds, he sought to establish how the steroid framework constrained the formation of different heterocyclic rings, with the possibility of obtaining derivatives of biological interest. His thesis documents the investigation across five ring families, its experimental limitations, and the reassignment of an earlier indolo-steroid structure.
After reviewing the earlier literature, Antaki identified the problem in his thesis (Part II, p. 94):
“the systematic study of the limitations in their preparation inherent in the steroid structure has not hitherto been attempted”
He then stated that Part II of the investigation had been undertaken with that objective in view (p. 94).
The results of the programme were published with V. Petrow in 1951 as Steroids and Related Compounds. Part XII. Some Heterocyclic Derivatives, Journal of the Chemical Society, 1951, 901–904. DOI: 10.1039/JR9510000901.
The 1951 paper reports the synthetic results; the 1950 thesis provides the fuller account of the original objective, reasoning and limitations.
A Multi-Family Steroidal Heterocycle Programme
The investigation did not concentrate on a single ring system. Antaki applied established heterocycle-forming reactions to steroid ketones and related intermediates and prepared representatives of several fused families: quinolino-steroids, indolo-steroids, pyrrolo-steroids, thiazolo-steroids, and a steroidal system described in the thesis using diazacarbazolo terminology and later in specialist literature as a triazafluoreno derivative.
The significance of the programme therefore lies not simply in the preparation of individual compounds, but in treating fused heterocyclic steroid synthesis as a systematic multi-family programme.
Later steroid-heterocycle reviews described a closely comparable rationale for the field. Akhrem and Titov's 1967 review discussed condensed heterocyclic steroids as a medicinal-chemistry strategy directed toward compounds with anabolic, anti-inflammatory, hypotensive, antitumour and other physiological activities.
A. A. Akhrem and Yu. A. Titov, “Derivatives of Steroids with Condensed Heterocycles,” Russian Chemical Reviews, 1967, 36, 311–325. DOI: 10.1070/RC1967v036n05ABEH001616.
Quinolino-Steroids
Antaki extended established quinoline-forming chemistry to additional steroid ketones and derivatives.
Earlier work by W. Borsche and R. Frank had produced quinoline-fused derivatives of 3:12-diketo- and 3:7:12-triketo-cholanic acids, reported without reference to their biological activity. Antaki and Petrow found that the condensation with o-aminobenzaldehyde extends to cholestan-3-one and to 3-ketoallocholanic acid, giving the corresponding quinolino-steroids in good yield, and that anthranilic acid with cholestan-3-one gives a 4′-hydroxyquinolino-steroid, converted through the 4′-chloro compound into 4′-amino and 4′-phenoxy analogues. Both linear and angular formulations were possible; they preferred the linear structures in view of the established reactivity of the C2 methylene group in ketones of this type, the same reasoning that underlies the indolo correction below. The basic 4′-amino compound was prepared for biological study and was the only member of the series sufficiently soluble for testing.
W. Borsche and R. Frank, Berichte der Deutschen Chemischen Gesellschaft, 1924, 57, 1373–1380. DOI: 10.1002/cber.19240570828.
Indolo-Steroids: Structural Correction
The indolo branch produced a different kind of contribution.
In 1935, Dorée and Petrow had formulated the Fischer-indole product obtained from cholestan-3-one as an angular indolo-cholestane. The thesis records that the formulation was supported by a study of molecular area in unimolecular films, the results of which were compatible with an angular structure, then the preferred formulation.
In his 1950 thesis, Antaki reconsidered that structure in light of the established chemistry of the cholestanones and reassigned the product to the linear indolo[2′:3′-3:2]cholestane structure.
“The original conclusions of Dorée and Petrow must therefore be reconsidered in the light of this new evidence…”
The argument is set out on pages 92–94 of the thesis. It is a clear chemical argument, built from several independent lines of evidence, not a single unequivocal reaction on the indole itself. Antaki drew on the evidence that had accumulated since 1935 on the relative reactivity of the C2 and C4 methylene groups, which showed that in the cholestanone series C2 is the active methylene group. Bromination gives 2-bromocholestanone (Butenandt and Wolff), selenium dioxide oxidation gives cholestan-2:3-dione (Rosenheim and Stiller), and sulphonation gives cholestan-3-one-2-sulphonic acid (Windaus and Kuhr). In each case the structure was established by conversion to known compounds, including, for the dione, the dicarboxylic acid obtained earlier by Windaus and Uibrig. The thesis concludes that the original formulation “must therefore be reconsidered”, which leads to the linear formulation. It also records the contrast in the coprostanone series, where C4 is the active position (bromination gives 4-bromocoprostanone, and sulphonation gives a mixture of the 2- and 4-sulphonic acids); the 1951 paper retained the angular formulation for the indole derived from coprostanone.
The reassignment was published in compressed form in Antaki and Petrow's 1951 paper (p. 902). DOI: 10.1039/JR9510000901.
Fourteen years later, Yoshio Ban and Yasuhiko Sato confirmed the structure experimentally by chemical degradation, carrying the product through ozonolysis and subsequent reactions to the known Windaus–Uibrig acid, the same acid the thesis had cited in establishing the C2-substituted cholestanone derivatives. Their paper records that the earlier angular formulation had been revised by Antaki and Petrow to the linear structure on the basis of the known reactivity of the C2 methylene group in the 5α-series, and that Antaki and Petrow preferred the angular structure for the product from 5β-cholestan-3-one. Their degradations established both: the linear structure for the 5α-series indole and the angular structure for the 5β-series indole.
Y. Ban and Y. Sato, “Studies on the Structures of Some Cholestanoindoles,” Chemical and Pharmaceutical Bulletin, 1965, 13, 1073–1077. DOI: 10.1248/cpb.13.1073.
B. Robinson's 1969 review of the Fischer indole synthesis (p. 237) likewise records the reformulation by Antaki and Petrow and Ban and Sato's confirmation of both structures.
B. Robinson, “Recent Studies on the Fischer Indole Synthesis,” Chemical Reviews, 1969, 69, 227–250. DOI: 10.1021/cr60258a004.
The corrected indolo-steroid subsequently remained a working structural precedent in later Fischer-indole chemistry. In their study of the Fischer-indole cyclisation of cholestan-3-one phenylhydrazones, Harvey and Reid cite Antaki and Petrow's 1951 paper for the formation of 5α-cholest-2-eno[3,2-b]indole from 5α-cholestan-3-one, and of 5β-cholest-3-eno[3,4-b]indole from 5β-cholestan-3-one, noting that the position of ring fusion parallels the direction of enolisation of the 3-oxo group and that both are governed by stereochemistry at C-5. They cite Ban and Sato for the establishment of these structures by chemical degradation.
D. J. Harvey and S. T. Reid, “The Fischer-Indole Cyclization of Phenylhydrazones and N-Methylphenylhydrazones of Some 6-Substituted Cholestan-3-ones,” Tetrahedron, 1972, 28, 2489–2506. DOI: 10.1016/0040-4020(72)80084-X.
A related steroidal indole framework also became part of a rigid molecular system used by Haugland, Yguerabide and Stryer in an experimental test of Förster's prediction that the rate of intramolecular singlet–singlet energy transfer is proportional to the spectral overlap of donor and acceptor. Their linearly fused indole–ketone steroid, 1′-methylindolo(3′,2′:2,3)-2(5α)-androsten-17-one, was prepared by the Fischer indole synthesis, citing Antaki and Petrow, with the site of fusion taken from Warnhoff and NaNonggai and from Ban and Sato.
R. P. Haugland, J. Yguerabide and L. Stryer, “Dependence of the Kinetics of Singlet-Singlet Energy Transfer on Spectral Overlap,” Proceedings of the National Academy of Sciences USA, 1969, 63, 23–30. DOI: 10.1073/pnas.63.1.23.
The same group of references reappears in 2002–2003 in a medicinal-chemistry paper on indole-fused triterpenoids. Finlay, Honda and Gribble, introducing their [3,2-b]indole-fused oleanolic acids, made by Fischer indolization of the 3-ketone, note that fused heterocyclic derivatives of steroids and alkaloids are well documented and cite, for earlier indole-fused steroids, Antaki and Petrow's 1951 paper first among four references (27–30), followed by Warnhoff and NaNonggai (1962), Ban and Sato (1965) and Haugland et al. (1969).
H. J. Finlay, T. Honda and G. W. Gribble, “Synthesis of Novel [3,2-b]Indole Fused Oleanolic Acids as Potential Inhibitors of Cell Proliferation,” ARKIVOC, 2002, (xii), 38–46 (published online 2 May 2003). DOI: 10.3998/ark.5550190.0003.c05.
Pyrrolo-Steroids: An Early Steroidal Knorr Synthesis
Antaki and Petrow also applied pyrrole-forming chemistry to the steroid nucleus.
Later specialist literature retained this synthesis in the history of steroidal pyrroles. In their 1967 review, Zhungietu and Dorofeenko describe use of the Knorr method for steroidal pyrrole formation, including the condensation leading to an ethyl carboxy-methyl pyrrolocholestane, and cite Antaki and Petrow's 1951 paper as the source.
G. I. Zhungietu and G. N. Dorofeenko, “Progress in the Field of the Chemistry of Steroidal Heterocycles,” Russian Chemical Reviews, 1967, 36 (1), 24–37 (Russian original: Uspekhi Khimii, 1967, 36, 48–76). DOI: 10.1070/RC1967v036n01ABEH001581.
Akhrem and Titov describe the same zinc-and-acetic-acid condensation of cholestane 3-ketosteroids with ethoxyiminoacetoacetate to give steroido[3,2-b]pyrroles and, in a footnote to that passage, cite Antaki and Petrow for the same method applied to 17-ketosteroids, which gave 5′-ethoxycarbonyl-4′-methylandrostano[17,16-b]pyrrole derivatives in low yield.
Thiazolo-Steroids: Later Development
Antaki and Petrow prepared a 2′-aminothiazolo-fused cholestane by reaction of a brominated steroid ketone with thiourea.
In 1962, Norman J. Doorenbos and Conrad P. Dorn Jr. published Steroids IX. Synthesis of Some Thiazolosteroids. They prepared 2′-aminothiazolo[d-3,2]-5α-cholest-2-ene by the same general chemistry and gave the earlier reported melting point (266°) and optical rotation (+64.4°), citing Antaki and Petrow 1951 as reference 13.
N. J. Doorenbos and C. P. Dorn Jr., “Steroids IX. Synthesis of Some Thiazolosteroids,” Journal of Pharmaceutical Sciences, 1962, 51, 414–417. DOI: 10.1002/jps.2600510504.
A dedicated 1981 review of steroidal thiazoles, isothiazoles, thiazolines and thiazolidines also includes Antaki and Petrow's 1951 paper among the early sources for steroido[3,2-d]thiazoles.
P. Catsoulacos and Ch. Camoutsis, “Steroidal Thiazoles, Isothiazoles, Thiazolines and Thiazolidines,” Journal of Heterocyclic Chemistry, 1981, 18, 1485–1505. DOI: 10.1002/jhet.5570180801.
Diazacarbazolo / Triazafluoreno Steroids
The thesis describes this branch of the programme using diazacarbazolo terminology.
Antaki and Petrow obtained the product from 2-hydroxymethylenecholestan-3-one and 2-aminobenzimidazole.
Akhrem and Titov, discussing a product obtained from the same two starting materials, identify it as cholestano[3,2-b]-1′,9′,11′-triazafluorene and cite Antaki and Petrow's 1951 paper as the source.
A. A. Akhrem and Yu. A. Titov, “Derivatives of Steroids with Condensed Heterocycles,” Russian Chemical Reviews, 1967, 36, 311–325. DOI: 10.1070/RC1967v036n05ABEH001616.
The compound was later re-prepared independently. In 1980, J. S. Bajwa and P. J. Sykes (University of Edinburgh), under the current name 5α-cholestano[3,2-b](pyrimido[1,2-a]benzimidazole), obtained it from 2-hydroxymethylene-5α-cholestan-3-one and 2-aminobenzimidazole, and cite Antaki and Petrow (their reference 3) for the earlier preparation of the cholestane compound. They record a melting point of 290–292 °C against 295 °C in the literature, and obtained the identical product (same melting point and infrared spectrum) by a second route from 2-[(2-pyridylamino)methylene]-5α-cholestan-3-one. Their 1H and 13C NMR studies of the androstane analogues support the linear [3,2-b] fusion that the 1951 paper had named (3′:2′-2:3) and the thesis [2′:3′-3:2].
J. S. Bajwa and P. J. Sykes, “New Steroidal Heterocycles: Androstano[3,2-b](pyrimido[1,2-a]benzimidazoles),” Journal of the Chemical Society, Perkin Transactions 1, 1980, 1859–1861. DOI: 10.1039/P19800001859.
Historical Record
The programme brought together quinolino-, indolo-, pyrrolo- and thiazolo-steroid chemistry, together with the branch described in the thesis using diazacarbazolo terminology. Later specialist literature continued to cite Antaki and Petrow's 1951 work in connection with the pyrrolo-, thiazolo- and triazafluoreno branches, while the indolo-steroid reassignment was subsequently confirmed and retained in later structural literature. Akhrem and Titov's 1967 review alone cites the 1951 paper (its reference 7) for the quinolino, indolo, thiazolo and triazafluoreno compounds and, in a footnote, for the pyrrolo-steroid method, covering every family in the programme.
More broadly, Antaki's 1950 thesis explicitly framed the work as a systematic investigation of heterocyclic ring formation within the steroid structure, undertaken with biological investigation in view. The 1951 paper then reported several distinct fused heterocyclic steroid families arising from that programme.
The historical significance of the work therefore rests most firmly on the documented conception and execution of a systematic, multi-family programme of fused heterocyclic steroid synthesis in 1950–1951.
From an Early Programme to a Field
By the 1960s, fused heterocyclic steroid chemistry had expanded substantially. Specialist reviews classified steroidal pyrroles, indoles, pyrazoles, thiazoles, triazoles, pyridines, quinolines, pyrimidines and other condensed systems, while medicinal studies explored how changing the fused heterocycle altered biological activity.
Akhrem and Titov summarized the mature rationale of the field in 1967: heterocyclic modification of the steroid skeleton was being pursued in the hope of producing compounds with biological properties different from those of the parent steroid, including anabolic, anti-inflammatory, hypotensive and antitumour effects.
That rationale is visible in Antaki's thesis seventeen years earlier. Immediately before stating his objective, he wrote:
“Heterocyclic derivatives of the steroids may thus possess valuable biological properties.”
His objective, quoted at the outset of this page, was the systematic study of the limitations in their preparation inherent in the steroid structure.
Later Work on the Same Problem: Chaplin, Hey and Honeyman, 1959
In the introduction to Part II of the thesis, Antaki wrote that introducing a basic nucleus into the steroid had not led to compounds of adequate solubility for biological study (p. 95). He nevertheless anticipated further progress:
“Nevertheless, the work described below does indicate in what direction further progress may be expected.”
The thesis shows what that direction was: a basic side chain, judged desirable for enhancing both solubility and biological activity (p. 97), with the steroidal alkaloids as the natural products motivating the work (pp. 84–88). His indolo-acids proved too insoluble even as potassium salts, and the hydrazide needed to reach a basic side chain was obtained only in poor yield (p. 101).
Nine years after the thesis (and eight after the 1951 paper they cite), A. F. Chaplin, D. H. Hey and J. Honeyman, in The Steroid Series. Part IV. Some Basic Derivatives (1959), took up the same design: an indolosteroid combined with a second basic group in the 17-side-chain, in the hope of obtaining water-soluble salts, motivated by the biological activity of the steroidal alkaloids. They cite Antaki and Petrow's 1951 paper twice (p. 3195): first as an earlier attempt to prepare such a compound, in which the required hydrazide was obtained only in very low yield; and second as the authority for the angular formulation of indolo-steroids from 3-keto-steroids of the normal series, which they adopt tentatively for their own product. By a different route they prepared 24-aminoindolo(2′:3′-3:4)chol-3-ene hydrochloride, and reported a dihydroxyindolosteroid acid to be more soluble in water than its non-hydroxylated analogue.
This is a documented example of later chemists taking up the design problem Antaki had set out and acknowledging his earlier attempt. The subsequent expansion of fused heterocyclic steroid chemistry, documented in specialist reviews, further demonstrates that the broader research direction he anticipated proved productive, independently of whether later developments descended directly from his individual syntheses.
A. F. Chaplin, D. H. Hey and J. Honeyman, “The Steroid Series. Part IV. Some Basic Derivatives,” Journal of the Chemical Society (1959), 3194–3202. DOI: 10.1039/JR9590003194.
References
- Antaki, H. B. F. Contributions to the Chemistry of Heterocyclic Compounds. PhD thesis, Queen Mary College, University of London, May 1950, Part II, from p. 83; indolo reassignment pp. 92–94; programme statement pp. 94–95. DOI: 10.17636/101132126.
- Antaki, H.; Petrow, V. Steroids and Related Compounds. Part XII. Some Heterocyclic Derivatives. J. Chem. Soc. 1951, 901–904. DOI: 10.1039/JR9510000901.
- Borsche, W.; Frank, R. Ber. Dtsch. Chem. Ges. 1924, 57, 1373–1380. DOI: 10.1002/cber.19240570828.
- Chaplin, A. F.; Hey, D. H.; Honeyman, J. The Steroid Series. Part IV. Some Basic Derivatives. J. Chem. Soc. 1959, 3194–3202. DOI: 10.1039/JR9590003194.
- Ban, Y.; Sato, Y. Studies on the Structures of Some Cholestanoindoles. Chem. Pharm. Bull. 1965, 13, 1073–1077. DOI: 10.1248/cpb.13.1073.
- Doorenbos, N. J.; Dorn, C. P. Jr. Steroids IX. Synthesis of Some Thiazolosteroids. J. Pharm. Sci. 1962, 51, 414–417. DOI: 10.1002/jps.2600510504.
- Zhungietu, G. I.; Dorofeenko, G. N. Progress in the Field of the Chemistry of Steroidal Heterocycles. Russ. Chem. Rev. 1967, 36 (1), 24–37 (Usp. Khim. 1967, 36, 48–76). DOI: 10.1070/RC1967v036n01ABEH001581.
- Akhrem, A. A.; Titov, Yu. A. Derivatives of Steroids with Condensed Heterocycles. Russ. Chem. Rev. 1967, 36, 311–325. DOI: 10.1070/RC1967v036n05ABEH001616.
- Robinson, B. Recent Studies on the Fischer Indole Synthesis. Chem. Rev. 1969, 69, 227–250. DOI: 10.1021/cr60258a004.
- Haugland, R. P.; Yguerabide, J.; Stryer, L. Dependence of the Kinetics of Singlet-Singlet Energy Transfer on Spectral Overlap. Proc. Natl. Acad. Sci. USA 1969, 63, 23–30. DOI: 10.1073/pnas.63.1.23.
- Harvey, D. J.; Reid, S. T. The Fischer-Indole Cyclization of Phenylhydrazones and N-Methylphenylhydrazones of Some 6-Substituted Cholestan-3-ones. Tetrahedron 1972, 28, 2489–2506. DOI: 10.1016/0040-4020(72)80084-X.
- Bajwa, J. S.; Sykes, P. J. New Steroidal Heterocycles: Androstano[3,2-b](pyrimido[1,2-a]benzimidazoles). J. Chem. Soc., Perkin Trans. 1 1980, 1859–1861. DOI: 10.1039/P19800001859.
- Catsoulacos, P.; Camoutsis, Ch. Steroidal Thiazoles, Isothiazoles, Thiazolines and Thiazolidines. J. Heterocycl. Chem. 1981, 18, 1485–1505. DOI: 10.1002/jhet.5570180801.
- Finlay, H. J.; Honda, T.; Gribble, G. W. Synthesis of Novel [3,2-b]Indole Fused Oleanolic Acids as Potential Inhibitors of Cell Proliferation. ARKIVOC 2002, (xii), 38–46 (published online 2 May 2003). DOI: 10.3998/ark.5550190.0003.c05.
Sources cited in the thesis (pp. 91–93) for the indolo reassignment:
- Dorée, C.; Petrow, V. J. Chem. Soc. 1935, 1391.
- Butenandt, A.; Wolff, A. Ber. Dtsch. Chem. Ges. 1935, 68, 2091.
- Windaus, A.; Kuhr, E. Justus Liebigs Ann. Chem. 1937, 532, 52.
- Rosenheim, O.; Stiller, H. J. Chem. Soc. 1938, 353.
- Windaus, A.; Uibrig, C. Ber. Dtsch. Chem. Ges. 1914, 47, 2384.
Earlier work reviewed in the thesis (Part II, pp. 83–91) and the 1951 paper (p. 901):
- Haslewood. Biochem. J. 1941, 35, 1307.
- Caldwell. J. Am. Chem. Soc. 1938, 60, 991; 1939, 61, 3584.
- Barnett; Ryman; Smith. J. Chem. Soc. 1946, 524, 528.
- James; Smith; Stacey; Webb. J. Chem. Soc. 1946, 665.
- Dorée, C. J. Chem. Soc. 1909, 95, 653.